Literature DB >> 20011311

Epidermoid carcinoma of the anal canal.

Bruce W Robb1, Matthew G Mutch.   

Abstract

Anal cancers are rare tumors with only an expected 4000 new diagnoses in 2005. The majority of these are epidermoid or squamous cell cancers. Despite the rarity of this disease, great advances have been made in its understanding and treatment. The human papillomavirus (HPV), immunosuppression for solid organ transplantation, the human immunodeficiency virus (HIV), and sexual practices are changing the demographics of the disease from elderly women to young men who have sex with men and young women infected with HPV and HIV. The treatment of these malignancies was radically changed with Dr. Nigro's description in 1974 of the use of a nonoperative treatment strategy. Today, radiochemotherapy represents first-line therapy and the role of surgery has been largely relegated to that of salvage therapy for treatment failures of nonoperative management.

Entities:  

Keywords:  Epidermoid cancer; anal canal; squamous cancer

Year:  2006        PMID: 20011311      PMCID: PMC2780104          DOI: 10.1055/s-2006-942345

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  56 in total

1.  On human papillomaviruses.

Authors:  P M Howley
Journal:  N Engl J Med       Date:  1986-10-23       Impact factor: 91.245

2.  Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.

Authors: 
Journal:  Lancet       Date:  1996-10-19       Impact factor: 79.321

3.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

4.  Radiotherapy for anal cancer: experience from 1979-1987.

Authors:  L L Hughes; T A Rich; L Delclos; J A Ajani; R G Martin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-12       Impact factor: 7.038

5.  Human papillomavirus DNA determination of anal condylomata, dysplasias, and squamous carcinomas with in situ hybridization.

Authors:  M A Duggan; V F Boras; M Inoue; S E McGregor; D I Robertson
Journal:  Am J Clin Pathol       Date:  1989-07       Impact factor: 2.493

6.  Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men.

Authors:  J M Palefsky; E A Holly; C J Hogeboom; M L Ralston; M M DaCosta; R Botts; J M Berry; N Jay; T M Darragh
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-04-01

7.  HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?

Authors:  Mark Bower; Tom Powles; Tom Newsom-Davis; Christina Thirlwell; Justin Stebbing; Sundihya Mandalia; Mark Nelson; Brian Gazzard
Journal:  J Acquir Immune Defic Syndr       Date:  2004-12-15       Impact factor: 3.731

8.  Carcinoma of the anal canal. A clinical and pathologic study of 188 cases.

Authors:  B M Boman; C G Moertel; M J O'Connell; M Scott; L H Weiland; R W Beart; L L Gunderson; R J Spencer
Journal:  Cancer       Date:  1984-07-01       Impact factor: 6.860

9.  Spectrum of AIDS-associated malignant disorders.

Authors:  J J Goedert; T R Coté; P Virgo; S M Scoppa; D W Kingma; M H Gail; E S Jaffe; R J Biggar
Journal:  Lancet       Date:  1998-06-20       Impact factor: 79.321

10.  Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy.

Authors:  M J Arends; E C Benton; K M McLaren; L A Stark; J A Hunter; C C Bird
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.